Although the evidence is not strong, we identified products with the most evidence behind them in our Tart Cherry article
The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment)
GLP-1 side effects and accessibility: what celebrity stories dont show Celebrity stories about GLP-1 medications like Ozempic, Wegovy, and Mounjaro often highlight the results, but theres more to the picture
your body has accomplished something remarkable, and finding your balance takes time
Primary care relevance: Providers should be aware of the differences in efficacy, cost, and convenience of available therapies SMALL STUDY LOOKS AT HOLDING GLP-1 ANALOGS BEFORE GI PROCEDURES April 2026 Randomized trial finds holding one preprocedure dose of a GLP-1 analog reduces residual gastric volume The issue: GLP-1 analogs are being increasingly prescribed for weight loss and type 2 diabetes, but their gastric-slowing effects have raised concerns about residual gastric volume (RGV) and potential pulmonary aspiration during procedures requiring sedation
